Monthly Round-Up of What to Read on Pharma Law and Policy
Bill of Health
JULY 1, 2022
Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19: meta-epidemiological study. Coverage of New Drugs in Medicare Part D. J Am Pharm Assoc (2003). 2022 May 10;377:e069400. 2022 May 3.
Let's personalize your content